Massimo A. Gianni

507 total citations
5 papers, 54 citations indexed

About

Massimo A. Gianni is a scholar working on Genetics, Pathology and Forensic Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Massimo A. Gianni has authored 5 papers receiving a total of 54 indexed citations (citations by other indexed papers that have themselves been cited), including 2 papers in Genetics, 2 papers in Pathology and Forensic Medicine and 2 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Massimo A. Gianni's work include Radiopharmaceutical Chemistry and Applications (2 papers), Mesenchymal stem cell research (2 papers) and Lymphoma Diagnosis and Treatment (2 papers). Massimo A. Gianni is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (2 papers), Mesenchymal stem cell research (2 papers) and Lymphoma Diagnosis and Treatment (2 papers). Massimo A. Gianni collaborates with scholars based in Italy and United States. Massimo A. Gianni's co-authors include Carmelo Carlo‐Stella, Massimo Di Nicola, Anna Guidetti, Paolo Longoni, Franca Formelli, Ettore Seregni, Marco Milanesi, Angela Coliva, Liliana Devizzi and Emilio Bombardieri and has published in prestigious journals such as European Journal of Nuclear Medicine and Molecular Imaging, Tumori Journal and PubMed.

In The Last Decade

Massimo A. Gianni

5 papers receiving 48 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Massimo A. Gianni Italy	4	17	17	14	14	13	5	54
Razeen Mahroof United Kingdom	3	9 0.5×	17 1.0×	16 1.1×	12 0.9×	21 1.6×	5	64
Lukas Kazianka Austria	4	24 1.4×	7 0.4×	28 2.0×	13 0.9×	5 0.4×	10	55
Adam J. Wood United States	7	14 0.8×	5 0.3×	21 1.5×	7 0.5×	11 0.8×	15	83
Donatella Russo Italy	7	11 0.6×	31 1.8×	3 0.2×	27 1.9×	12 0.9×	14	93
Astrid Pavlovsky Argentina	5	22 1.3×	8 0.5×	32 2.3×	6 0.4×	11 0.8×	21	62
Alfred Leipold Germany	4	19 1.1×	13 0.8×	10 0.7×	3 0.2×	9 0.7×	9	48
Michael Pearlman United States	5	36 2.1×	26 1.5×	12 0.9×	6 0.4×	29 2.2×	9	117
Sergey Voloshin Russia	5	27 1.6×	43 2.5×	18 1.3×	12 0.9×	27 2.1×	50	87
Gavin Preston United Kingdom	5	17 1.0×	14 0.8×	36 2.6×	3 0.2×	28 2.2×	10	72
Tim Röhnisch Germany	3	34 2.0×	7 0.4×	8 0.6×	6 0.4×	11 0.8×	3	49

Countries citing papers authored by Massimo A. Gianni

Since Specialization

Citations

This map shows the geographic impact of Massimo A. Gianni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Massimo A. Gianni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Massimo A. Gianni more than expected).

Fields of papers citing papers by Massimo A. Gianni

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Massimo A. Gianni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Massimo A. Gianni. The network helps show where Massimo A. Gianni may publish in the future.

Co-authorship network of co-authors of Massimo A. Gianni

This figure shows the co-authorship network connecting the top 25 collaborators of Massimo A. Gianni. A scholar is included among the top collaborators of Massimo A. Gianni based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Massimo A. Gianni. Massimo A. Gianni is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

5 of 5 papers shown

1.

Chiesa, Claudio, Francesca Botta, Angela Coliva, et al.. (2009). Absorbed dose and biologically effective dose in patients with high-risk non-Hodgkin’s lymphoma treated with high-activity myeloablative 90Y-ibritumomab tiuxetan (Zevalin®). European Journal of Nuclear Medicine and Molecular Imaging. 36(11). 1745–1757. 15 indexed citations

2.

Carlo‐Stella, Carmelo & Massimo A. Gianni. (2004). Biology and clinical applications of marrow mesenchymal stem cells. Pathologie Biologie. 53(3). 162–164. 8 indexed citations

3.

Carlo‐Stella, Carmelo, Massimo Di Nicola, Michele Magni, et al.. (2002). Defibrotide in combination with granulocyte colony-stimulating factor significantly enhances the mobilization of primitive and committed peripheral blood progenitor cells in mice.. PubMed. 62(21). 6152–7. 21 indexed citations

4.

Conconi, Annarita, Catherine Thieblemont, Andrés J.M. Ferreri, et al.. (2002). Activity of Rituximab in Extranodal Marginal Zone Lymphomas (MALT Type). 7 indexed citations

5.

Chiti, Arturo, Massimo Di Nicola, Antonella Spinelli, et al.. (1998). A Case of Metastatic Axillary Lymph Nodes Involvement from Unknown Primary Cancer: Clinical Usefulness of [^99mTc]-Sestamibi. Tumori Journal. 84(5). 612–613. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact